1. Home
  2. TRN vs GPCR Comparison

TRN vs GPCR Comparison

Compare TRN & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Trinity Industries Inc.

TRN

Trinity Industries Inc.

HOLD

Current Price

$34.09

Market Cap

2.6B

Sector

Industrials

ML Signal

HOLD

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

HOLD

Current Price

$41.54

Market Cap

2.8B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRN
GPCR
Founded
1933
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Railroads
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.8B
IPO Year
1994
2023

Fundamental Metrics

Financial Performance
Metric
TRN
GPCR
Price
$34.09
$41.54
Analyst Decision
Hold
Strong Buy
Analyst Count
1
12
Target Price
$34.00
$103.17
AVG Volume (30 Days)
703.7K
640.1K
Earning Date
04-30-2026
05-08-2026
Dividend Yield
4.03%
N/A
EPS Growth
85.98
N/A
EPS
0.30
N/A
Revenue
$2,156,900,000.00
N/A
Revenue This Year
$1.91
N/A
Revenue Next Year
$15.61
N/A
P/E Ratio
$113.83
N/A
Revenue Growth
N/A
N/A
52 Week Low
$22.38
$15.80
52 Week High
$37.36
$94.90

Technical Indicators

Market Signals
Indicator
TRN
GPCR
Relative Strength Index (RSI) 55.62 54.44
Support Level $31.12 $30.82
Resistance Level $35.33 $57.23
Average True Range (ATR) 1.02 2.07
MACD 0.12 0.71
Stochastic Oscillator 82.73 73.02

Price Performance

Historical Comparison
TRN
GPCR

About TRN Trinity Industries Inc.

Trinity Industries Inc sells and leases railroad products and railcar maintenance services in North America. The company operates under the name TrinityRail in two main segments: railcar leasing and management services, which owns railcars and provides fleet management and administration services; rail products, which builds, sells, and modifies freight and tank railcars and their components; and all other, which sells highway products such as guardrail and other highway barriers. Customers include railroads, leasing companies, and shipping companies in agriculture, construction, consumer products, energy, and chemicals.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: